MBD2 and cancer: Similarly, mutations (nonsense mutation, frameshift mutation, deletion, insertion etc.)in KDM6A in different cancers (renal, pancreatic, bladder, esophageal, myeloma etc.)cause the premature termination of codons and results in the loss of demethylase activity.